At Takeda, one of the top priorities in the R&D group since the $62 billion acquisition of Shire closed at the beginning of the year has been centered on creating a shared culture — and that calls for some group activities.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,